MedPath

CIS BIO INTERNATIONAL

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:4
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 3:1

Drug Approvals

23

CIMA_AEMPS:21
EMA:2

Drug Approvals

Striascan

Authorization Status
Authorised
Approval Date
Jun 25, 2019
EMA

Quadramet

Authorization Status
Authorised
Approval Date
Feb 4, 1998
EMA

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 3
1 (33.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.